Tahoe Therapeutics has secured $30 million in new funding aimed at driving cutting‐edge advancements in medical research through AI. The capital injection will help develop detailed datasets and virtual cell models designed to expedite drug discovery and diagnostics. Not exactly a pill in a bottle, but a promising step forward.
Back to Top / Monday, August 11, 2025, 3:21 pm / permalink 12077 / 1 stories in 6 months
Numeral secures $35M to power its AI-based sales tax platform / 5 months
Reflection AI Nears $5.5B Valuation Amid AI Frenzy / 5 months
Scintil Photonics Fuels AI Innovation with Major Funding Boost / 5 months
ArcaScience secures $7M for AI-powered drug development innovation / 6 months
Attio Secures $52M Series B Funding to Boost AI CRM Innovation / 6 months
Cohere secures $500M funding with ex‑Meta AI hire / 6 months
xAI’s $12B push fuels AI race amid internal dissent / 7 months
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.